Current concepts in giant cell (temporal) arteritis (Q41650340)

6 October 2017

1 reference

title

Current concepts in giant cell (temporal) arteritis (English)

1 reference

6 October 2017

Ghanchi FD

1

1 reference

6 October 2017

Dutton GN

series ordinal

2

1 reference

6 October 2017

publication date

1 September 1997

1 reference

6 October 2017

published in

Survey of Ophthalmology

1 reference

6 October 2017

volume

42

1 reference

6 October 2017

issue

2

1 reference

6 October 2017

page(s)

99-123

1 reference

Biliary ultrastructural changes in the liver in a case of giant cell arteritis

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Visual prognosis in giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Skip areas in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Histologic and ultrastructural characteristics of temporal arteritis. The value of the temporal artery biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal artery biopsy and corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal artery biopsy in giant-cell arteritis. A reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Immunological studies in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Long-term corticosteroid treatment in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Acute phase reactants in the initial phase of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Surgical pathology of cranial arteritis and polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Thresholds in cerebral ischemia - the ischemic penumbra

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Immunohistologic and cytochemical studies of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Ophthalmoplegia in cranial arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

[Epidemiologic approach to Horton's disease in the department of Loire-Atlantique. 110 cases in 10 years (1970-1979)]

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The use of Doppler flow studies in the diagnosis of giant cell arteritis. Selection of temporal artery biopsy site is facilitated

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Optic disc structure in anterior ischemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Anterior Ischemic Optic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis--the need for prolonged treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

A case of giant-cell arteritis and Horner's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Epidemiology of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Decrease of the OKT8 positive T cell subset in polymyalgia rheumatica. Lack of correlation with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Cortisone therapy of visual loss in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Clinical and laboratory findings with giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Use of the Doppler probe to detect the course of the superficial temporal artery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Excess mortality in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

In vitro cytotoxicity of human endothelial cells in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Ischaemic optic neuropathy. The clinical profile and history

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Orbital infarction syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Ocular pneumoplethysmography can help in the diagnosis of giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

1 reference

7 January 2021

Bilateral blindness in temporal arteritis with skip areas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Neurologic complications of giant cell (temporal) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Neurologic disease in biopsy-proven giant cell (temporal) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Central retinal artery occlusion in giant cell arteritis: treatment with nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Serologic and immunopathologic findings in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Cortical blindness in cranial arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

IV steroids for central retinal artery occlusion in giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis; a generalized vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Bilateral internuclear ophthalmoplegia--an unusual initial presenting sign of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Occult temporal arteritis. A common cause of blindness in old age

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Ophthalmic complications of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Tonic pupil with giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Inflammation of the uveal tract as a presenting feature of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis presenting as oculomotor nerve palsy with pupillary dilatation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Tonic pupil after temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis: the silent presentation and delay in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Treatable blindness in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Brainstem vascular accidents and cranial arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Ophthalmoplegia, ptosis, and miosis in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Production of interleukin 6 by granulomas of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Intracranial involvement of giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

C-Reactive Protein in Giant Cell (Cranial, Temporal) Artentis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Reversible choroidal vascular insufficiency without infarction in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Elevation of von willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Branch retinal artery occlusion as the initial sign of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The sensation of facial swelling in temporal arteritis: a predictor for the development of visual disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Active giant cell arteritis with cerebral involvement. Findings following four years of corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Immunohistochemical findings in cranial arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

1 reference

7 January 2021

Marginal Corneal Ulceration (Limbal Guttering) as a Presenting Sign of Temporal Arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Facial swelling in giant cell (temporal) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Colour Doppler imaging in giant cell (temporal) arteritis: serial examination and comparison with non-arteritic anterior ischaemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Prognosis in giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

[Doppler ultrasound sonography of the supratrochlear artery in temporal arteritis (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Plasma viscosity in giant cell arteritis as a predictor of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The therapeutic impact of temporal artery biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant Cell Arteritis in the Ocular Ischemic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Prognosis and prognostic factors of retinal infarction: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

THE OPHTHALMIC ARTERY: III. BRANCHES.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Anterior ischaemic optic neuropathy. II. Fundus on ophthalmoscopy and fluorescein angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Posterior Ischemic Optic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Acute occlusive disorders of the choroidal vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Ophthalmic features of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Occlusion of the posterior ciliary artery. I. Effects on choroidal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis: validity and reliability of various diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Rheumatic disorders of the eye and the various structures involved

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Histopathology of ischemic optic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant-cell (temporal) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Methotrexate treatment in the management of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Color Doppler hemodynamics of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Effect of Posture on Retinal Ischemia From Temporal Arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Neurologic aspects of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Complications of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Dynamic tonometry. V. Further studies of the corneal indentation pulse in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Crest time evaluation of corneal indentation pulse. A new parameter in the study of ocular blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell (cranial) arteritis: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Hutchinson's Archives of Surgery Revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Erythrocyte sedimentation rate and its relationship to hematocrit in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis. A 14-year epidemiological, clinical and prognostic study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Clinical features of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Cytostatic drugs in the treatment of severe vasculitides. Indications, results and risks

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

A case of temporal arteritis successfully treated with recombinant interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis with normal sedimentation rate.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Occipital artery biopsy: a diagnostic alternative in giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Anterior ischaemic optic neuropathy and intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant-cell arteritis. Signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Monozygotic twins with temporal arteritis and ophthalmic arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Prevalence and evolution of anticardiolipin antibodies in giant cell arteritis during corticosteroid therapy. A prospective study of 20 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Immunohistology of temporal arteritis: phenotyping of infiltrating cells and deposits of complement components

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis. II. Electron microscopic study on consecutive biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Laboratory investigations including liver in polymyalgia rheumatica/giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Treatment of polymyalgia rheumatica/giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Stopping steroids in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Orbital pseudotumour secondary to giant cell arteritis: an unreported condition

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Immunoglobulins in temporal arteries. An immunofluorescent study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Occidental (temporal) and oriental (takayasu) giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Diplopia as early sign of temporal arteritis. report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Scleritis and temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Increased frequency of HLA-DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Cotton-wool spots in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Complications of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis. Clinical features and involvement of different organs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Immune complexes, rheumatoid factors, and cellular immunological parameters in patients with giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Retinal artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Optic disk size in ischemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Visual Recovery in Two Patients after Intravenous Methylprednisolone Treatment of Central Retinal Artery Occlusion Secondary to Giant-cell Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Anticardiolipin antibodies in the polymyalgia rheumatica-temporal arteritis syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Electroretinal responses in ocular vascular occlusions due to temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Fundus signs in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Cotton-wool Spots and the Early Diagnosis of Giant Cell Arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Reversal of blindness in temporal arteritis with methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis of the posterior cerebral circulation presenting with ataxia and ophthalmoplegia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Prognosis of polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Prevention of blindness in giant cell arteritis by corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis. A case with unusual neurologic manifestations and a normal sedimentation rate

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Epidemiology of biopsy-proven giant cell arteritis (GCA).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal artery morphology and morphometry in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis in a large necropsy series

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

An additional test for the diagnosis and monitoring of giant cell arteritis and polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Circulating immune complexes in giant cell arteritis and polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Immunological and histological study of temporal arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Circulating immune complexes in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal doppler-flow studies for suspected giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Choroidal nonperfusion in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Acute ocular hypotony. A rare complication of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Ocular manifestation of temporal arteritis. Immunological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Injury and repair of smaller muscular and elastic arteries. Immunohistochemical demonstration of fibronectin and fibrinogen/fibrin and their degradation products in rabbit femoral and common carotid arteries following a dilatation injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Short posterior ciliary artery insufficiency with hyperthermia (Uhthoff's symptom).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis. I. Smooth muscle cell involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Treatment of temporal arteritis with ocular involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

A case of temporal arteritis with intrahepatic arterial involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Anticardiolipin antibodies in northern Italian population with PMR/GCA

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Corticosteroid osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Epidemiology and mortality in 220 patients with polymyalgia rheumatica.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

T lymphocytes in giant cell arteritic lesions are polyclonal cells expressing alpha beta type antigen receptors and VLA-1 integrin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis. Comparison of histological and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Colour Doppler sonography to diagnose temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Optic disc cupping in arteritic anterior ischemic optic neuropathy resembles glaucomatous cupping

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis: cell composition and the possible pathogenetic role of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Fluorescein angiography in the diagnosis of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Transient oculomotor synkinesis in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Visual loss caused by choroidal ischemia preceding anterior ischemic optic neuropathy in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant cell arteritis in Jerusalem: a 12-year epidemiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The erythrocyte sedimentation rate. Guidelines for rational use.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Acute sectorial choroidal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Anterior ischaemic optic neuropathy. A correlative clinical and visual evoked potential study of 18 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal artery biopsy after one month of corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Internuclear ophthalmoplegia in giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis and polymyalgia rheumatica: nosographic and nosologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Acute transient ophthalmomalacia in giant-cell arteritis. Report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Why perform Doppler sonography before every biopsy of the temporal artery?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Visual system involvement in giant cell (temporal) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Antiphospholipid antibodies in the aetiology of ischaemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Severe anemia as the presenting manifestation of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal artery biopsies. Correlation of light microscopy and immunofluorescence microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Cyclosporine: a new adjuvant therapy for giant cell arteritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Disease patterns and tissue cytokine profiles in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

1 reference

7 January 2021

Haemorheological parameters in patients with retinal artery occlusion and anterior ischaemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Color Doppler velocimetry of the optic nerve head in arterial occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Colour Doppler ultrasound in the management of a case of cranial arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Color Doppler ultrasound imaging of the eye and orbit

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis with low erythrocyte sedimentation rate: A review of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Necrosis of choroidal melanoma: in ciliary artery involvement with temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Headache and temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

An alternate-day corticosteroid regimen in maintenance therapy of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Temporal arteritis--progressive affection of vision during high-level corticosteroid therapy. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

A study of elastic tissue and actinic radiation in "aging," temporal arteritis, polymyalgia rheumatica, and atherosclerosis. The actinic storm in the modern world

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900052-0

7 January 2021

10.1016/S0039-6257(97)00052-0

Identifiers

DOI

1 reference

6 October 2017

1 reference